Toshikazu Moriwaki

15PUBLICATIONS
80CO-AUTHORS
Cancer therapy (excl. chemotherapy and radiation therapy)Predictive and prognostic markersGene expression (incl. microarray and other genome-wide approaches)Liquid biopsies
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Journal

Publications (15)

|Mar 04, 2026
Comparison of first-line cetuximab and panitumumab plus doublet chemotherapies for left-sided colorectal cancer: a multicenter real-world observational study by the Japanese Society for Cancer of the Colon and Rectum.

Ryosuke Kawagoe, Toshikazu Moriwaki, Kentaro Yamazaki

|May 08, 2025
A multicenter, prospective, observational study of nivolumab readministration for advanced gastric cancer (NIVO RETURNS).

Hiroyuki Kodama, Yukiya Narita, Michio Nakamura

|Feb 13, 2025
BRAF V600E and Non-V600E Mutations in RAS Wild-Type Metastatic Colorectal Cancer: Prognostic and Therapeutic Insights from a Nationwide, Multicenter, Observational Study (J-BROS).

Hiroya Taniguchi, Kay Uehara, Toshiaki Ishikawa

|Aug 28, 2024
Real-world outcomes of FOLFOXIRI plus bevacizumab in patients with metastatic colorectal cancer: the JSCCR-TRIPON study.

Yoshiyuki Yamamoto, Hiroki Yukami, Tatsuro Yamaguchi

|Jun 21, 2023
Clinical Validation of Plasma-Based Genotyping for RAS and BRAF V600E Mutation in Metastatic Colorectal Cancer: SCRUM-Japan GOZILA Substudy.

Yu Aoki, Yoshiaki Nakamura, Tadamichi Denda

|Mar 30, 2023
Efficacy of Targeted Trials and Signaling Pathway Landscape in Advanced Gastrointestinal Cancers From SCRUM-Japan GI-SCREEN: A Nationwide Genomic Profiling Program.

Yoshiaki Nakamura, Riu Yamashita, Wataru Okamoto

Pageof 3

Frequent Collaborators

4 joint publications

Tadamichi Denda

4 joint publications

Takayuki Yoshino

3 joint publications

Yu Sunakawa

3 joint publications

Hiroya Taniguchi